Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoh Takekuma

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 1, 2023
Risk factor analysis for anti-epidermal growth factor receptor monoclonal antibody-induced skin toxicities in real-world metastatic colorectal cancer treatmentYoshitaka Saito, Kazuki Uchiyama, Yoh Takekuma, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 18, 2005
The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH-independent controlled-release formulationsMitsuru Sugawara, Shota Kadomura, Xin He, et al.
Biological & Pharmaceutical Bulletin|August 5, 2014
Schedule-dependent cytotoxicity of Etoposide and cyclophosphamide in P-glycoprotein-expressing human leukemic K-562 cellsYuki Tazawa, Ippei Usukubo, Kazuki Takada, et al.
European Journal of Clinical Pharmacology|September 28, 2021
Investigation of the risk factors of vomiting during linezolid therapy: a retrospective observational studyTakezo Tsutsumi, Shungo Imai, Hitoshi Kashiwagi, et al.
In Vivo (Athens, Greece)|June 27, 2025
Relationship Between Anthracycline-cyclophosphamide Regimens and Docetaxel Monotherapy in Oral Mucositis DevelopmentYoshitaka Saito, Tatsuhiko Sakamoto, Yoh Takekuma, et al.
Biological & Pharmaceutical Bulletin|November 1, 2023
Effects of Body Composition on Renal Function Estimates in Older PatientsSoyoko Kaburaki, Shungo Imai, Hitoshi Kashiwagi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 22, 2020
Pharmacokinetics of mycophenolic acid after haplo-hematopoietic stem cell transplantation in Japanese recipientsKazuki Uchiyama, Yoshitaka Saito, Yoh Takekuma, et al.
Biological & Pharmaceutical Bulletin|October 1, 2020
Prescription of Colchicine with Other Dangerous Concomitant Medications: A Nation-Wide Survey Using the Japanese Claims DatabaseShungo Imai, Kenji Momo, Hitoshi Kashiwagi, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 27, 2023
Monitoring Salivary Concentrations of Tedizolid and Linezolid Using RatsYuki Inoue, Yuki Sato, Hitoshi Kashiwagi, et al.
Anticancer Research|December 31, 2021
A 5% Glucose Solution for the Liquid Formulation Gemcitabine Solvent Decreases Gemcitabine-induced Vascular PainKazuki Uchiyama, Yoshitaka Saito, Tatsuhiko Sakamoto, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 1, 2023
Risk factor analysis for anti-epidermal growth factor receptor monoclonal antibody-induced skin toxicities in real-world metastatic colorectal cancer treatmentYoshitaka Saito, Kazuki Uchiyama, Yoh Takekuma, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 18, 2005
The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH-independent controlled-release formulationsMitsuru Sugawara, Shota Kadomura, Xin He, et al.
Biological & Pharmaceutical Bulletin|August 5, 2014
Schedule-dependent cytotoxicity of Etoposide and cyclophosphamide in P-glycoprotein-expressing human leukemic K-562 cellsYuki Tazawa, Ippei Usukubo, Kazuki Takada, et al.
European Journal of Clinical Pharmacology|September 28, 2021
Investigation of the risk factors of vomiting during linezolid therapy: a retrospective observational studyTakezo Tsutsumi, Shungo Imai, Hitoshi Kashiwagi, et al.
In Vivo (Athens, Greece)|June 27, 2025
Relationship Between Anthracycline-cyclophosphamide Regimens and Docetaxel Monotherapy in Oral Mucositis DevelopmentYoshitaka Saito, Tatsuhiko Sakamoto, Yoh Takekuma, et al.
Biological & Pharmaceutical Bulletin|November 1, 2023
Effects of Body Composition on Renal Function Estimates in Older PatientsSoyoko Kaburaki, Shungo Imai, Hitoshi Kashiwagi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 22, 2020
Pharmacokinetics of mycophenolic acid after haplo-hematopoietic stem cell transplantation in Japanese recipientsKazuki Uchiyama, Yoshitaka Saito, Yoh Takekuma, et al.
Biological & Pharmaceutical Bulletin|October 1, 2020
Prescription of Colchicine with Other Dangerous Concomitant Medications: A Nation-Wide Survey Using the Japanese Claims DatabaseShungo Imai, Kenji Momo, Hitoshi Kashiwagi, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 27, 2023
Monitoring Salivary Concentrations of Tedizolid and Linezolid Using RatsYuki Inoue, Yuki Sato, Hitoshi Kashiwagi, et al.
Anticancer Research|December 31, 2021
A 5% Glucose Solution for the Liquid Formulation Gemcitabine Solvent Decreases Gemcitabine-induced Vascular PainKazuki Uchiyama, Yoshitaka Saito, Tatsuhiko Sakamoto, et al.
Pageof 18